<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="38870">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02600364</url>
  </required_header>
  <id_info>
    <org_study_id>DP64/BO1507</org_study_id>
    <nct_id>NCT02600364</nct_id>
  </id_info>
  <brief_title>Diversion-p64 Post Market Clinical Follow-Up Study to Assess Safety and Effectiveness of the p64 Flow Modulation Device</brief_title>
  <official_title>Prospective, Multicenter, Single Arm Post Market Clinical Follow-Up Study to Assess Safety and Effectiveness of the p64 Flow Modulation Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Phenox GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Phenox GmbH</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess safety and effectiveness of the p64 Flow Modulation
      Device.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Title: Diversion-p64. Device: p64 Flow Modulation Device. Study design: Prospective,
      multicenter, single arm Post Market Clinical Follow-Up Study.

      Purpose: To assess safety and effectiveness of p64. Study duration: 30 months. Sample Size:
      107 patients. Number of sites: up to 20. Follow-up intervals: 3-6 and 12 months clinical and
      angiographic follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the rate of complete occlusion</measure>
    <time_frame>immediately after treatment, an expected average of 1 hour; to 12 months</time_frame>
    <description>Rate of complete aneurysm occlusion is assessed immediately after treatment (an expected average of 1 hour) and at both follow-up visits (3-6 months and 12 months). The change is assesed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of frequency of major stroke (ischemic or hemorrhagic) or neurological death related to the treatment of the target aneurysm</measure>
    <time_frame>immediately after treatment, an expected average of 1 hour; to 12 months</time_frame>
    <description>Frequency of major stroke (ischemic or hemorrhagic) or neurological death is assessed immediately after treatment (an expected average of 1 hour) and at both follow-up visits (3-6 months and 12 months). The change is assesed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intra-procedural technical complications</measure>
    <time_frame>during treatment, an expected average of 1 hour</time_frame>
    <description>p64 deployed in the desired location Correct opening of p64 (markers fully deployed) at the end of the procedure Ability to detach p64 at the end of the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Angiographic results</measure>
    <time_frame>immediately after treatment, an expected average of 1 hour; to 12 months</time_frame>
    <description>Change in both Rate of re-growth (related rate of re-treatment) and Rate of recanalization (related rate of re-treatment) is assessed immediately after treatment (an expected average of 1 hour) and at both follow-up visits (3-6 months and 12 months).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-procedural vascular complications</measure>
    <time_frame>during treatment, an expected average of 1 hour</time_frame>
    <description>Vessel perforation (e.g. with distal wire tip of p64, microcatheter) Target aneurysm perforation (e.g. with distal wire tip of p64, microcatheter) Thromboembolism Dissection of any access vessel Side branch occlusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-procedural Complications</measure>
    <time_frame>3-6 and 12 months</time_frame>
    <description>New parenchymal hemorrhage during the follow-up period New subarachnoid hemorrhage during the follow-up period New ischemic stroke on follow-up imaging Rupture of the target aneurysm during the follow-up period Rate of in-stent-stenosis</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">107</enrollment>
  <condition>Intracranial Aneurysm</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The target population for this non-interventional study are patients with ruptured or
        unruptured aneurysms and segmental diseases in the anterior circulation. Patients can be
        included in the study if they meet all of the inclusion and none of the exclusion criteria
        and have provided written informed consent.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age ≥ 18

          2. Patient harbours either a saccular or dissecting or blister-like or fusiform
             intracerebral aneurysm or an intracerebral segmental disease, in the anterior
             circulation for which the indication for p64 treatment is given

          3. Patient or legal representative provides written informed consent verifying that
             he/she consents to the use of his/her data (according to the data protection laws)

        Exclusion Criteria:

          1. Aneurysms of the posterior circulation

          2. Imaging evidence of bifurcation aneurysms

          3. Imaging evidence of dissections

          4. Imaging evidence of fistulae

          5. Imaging evidence of arteriovenous malformations

          6. Patient is harbouring another aneurysm that has to be treated within six months after
             first procedure

          7. Known allergy to study medication, e.g. ASA, Clopidogrel, Heparin or contrast media

          8. Pregnant or breast feeding women or women with child-bearing potential who cannot
             provide a negative pregnancy test
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alain Bonafé, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Gui de Chauliac (CHU de Montpellier), Montpellier, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sabine Konopka</last_name>
    <phone>+49 0234 36919</phone>
    <phone_ext>0</phone_ext>
    <email>Diversion-p64@phenox.info</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yvonne Treffner, Dr.</last_name>
    <phone>+49 0234 36919</phone>
    <phone_ext>0</phone_ext>
    <email>Diversion-p64@phenox.info</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ziekenhuis Oost-Limburg</name>
      <address>
        <city>Genk</city>
        <zip>3600</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luc Stockx, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Jean Minjoz (CHU Besançon)</name>
      <address>
        <city>Besancon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alessandra Biondi, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier Barreau, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Pierre Wertheimer</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francis Turjman, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Bicêtre</name>
      <address>
        <city>Le Kremlin-Bicêtre Cedex</city>
        <zip>94275</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laurent Spelle, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Gui de Chauliac (CHU Montpellier)</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain Bonafé, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Bretonneau (CHRU de Tours)</name>
      <address>
        <city>Tours cedex 9</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Paula Narata, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Augsburg</name>
      <address>
        <city>Augsburg</city>
        <zip>86156</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ansgar Berlis, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Bremen-Mitte</name>
      <address>
        <city>Bremen</city>
        <zip>28205</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christian Roth, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Knappschaftskrankenhaus Recklinghausen</name>
      <address>
        <city>Recklinghausen</city>
        <zip>45657</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Loehr, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Regensburg</name>
      <address>
        <city>Regensburg</city>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christina Wendl, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Stuttgart Katharinenhospital</name>
      <address>
        <city>Stuttgart</city>
        <zip>70174</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Aguilar Pérez, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>A.O.U. Policlinico Federico II</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Francesco Briganti, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>A.O.U. Città della Salute e della Scienza Osp. Molinette</name>
      <address>
        <city>Torino</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mauro Bergui, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>ASL TO2 San Giovanni Bosco</name>
      <address>
        <city>Torino</city>
        <zip>10154</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Simone Comelli, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>A.O.U. Integrata di Verona Ospedale Borgo Trento</name>
      <address>
        <city>Verona</city>
        <zip>37126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elisa Ciceri, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>ULSS6 San Bortolo di Vicenza</name>
      <address>
        <city>Vicenza</city>
        <zip>36100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Giuseppe Iannucci, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínic de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Juan Miguel Macho, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Western General Hospital</name>
      <address>
        <city>Edinburgh</city>
        <zip>EH4 2XU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Keston, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Leeds Teaching Hospitals NHS TRUST</name>
      <address>
        <city>Leeds</city>
        <zip>LS1 3EX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tufail Patankar, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St George's Hospital</name>
      <address>
        <city>London</city>
        <zip>SW17 0QT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrew Clifton, Dr.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Spain</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://phenox.net/</url>
    <description>www.phenox.net</description>
  </link>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 28, 2016</lastchanged_date>
  <firstreceived_date>November 4, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aneurysm</keyword>
  <keyword>intracerebral</keyword>
  <keyword>stroke</keyword>
  <keyword>p64</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Intracranial Aneurysm</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
